Putative melatonin receptors in benign human prostate tissue

Area of Science:

• Endocrinology
• Urology
• Molecular Biology

Background:

• Melatonin, a pineal gland hormone, is known to inhibit pubertal development and may suppress prostate growth.
• Age-related decline in melatonin production correlates with increased prevalence of benign prostate hypertrophy (BPH) in humans.

Purpose of the Study:

• To investigate the presence of melatonin binding sites in human BPH tissue.
• To explore a potential causal relationship between reduced melatonin and BPH development.

Main Methods:

• In vitro autoradiography using 125I-labeled melatonin (125I-melatonin) on human BPH tissue.
• Separation and subcellular fractionation to localize binding sites.
• Kinetic, equilibrium, and competition binding experiments to characterize binding properties.

Main Results:

• Specific 125I-melatonin binding was detected in the glandular epithelium of human BPH tissue, localized to the microsomal fraction.
• Binding was time-dependent, reversible, and exhibited high and low affinity characteristics.
• Melatonin competitively inhibited binding, with partial inhibition by a melatonin antagonist (ML-23) and minimal effect from serotonin or other tryptamines.

Conclusions:

• The findings indicate the presence of putative melatonin receptors in the human prostate epithelium.
• These receptors may be involved in the regulation of prostate growth and potentially BPH development.